Consolidated statement of changes in equity (Note 16)

x € million	Share capital	Share premium	Treasury shares	Other reserves	Retained earnings	Total	Non-controlling interests	Total Equity

Balance at 1 January 2019	338	489	(371)	(55)	7,381	7,782	33	7,815

Dividend	-	-	-	-	(414)	(414)	(4)	(418)
Options / performance shares granted	-	-	-	34	-	34	-	34
Options / performance shares vested / canceled	-	-	-	(36)	36	-	-	-
Reissued shares	-	-	335	-	(11)	324	-	324
Acquisition of NCI without a change in control	-	-	-	-	(13)	(13)	9	(4)
Acquisition (divestment) of subsidiary with NCI	-	-	-	-	-	-	57	57
Repurchase of shares	-	-	(869)	-	-	(869)	-	(869)
Transfer	-	-	-	4	(4)	-	-	-
Other	-	-	-	1	(10)	(9)	1	(8)
Total comprehensive income	-	-	-	148	748	896	8	904
Balance at 31 December 2019	338	489	(905)	96	7,713	7,731	104	7,835

Dividend	-	-	-	-	(423)	(423)	(6)	(429)
Options / performance shares granted	-	-	-	29	-	29	-	29
Options / performance shares vested / canceled	-	-	-	(39)	39	-	-	-
Reissued shares	-	-	238	-	(32)	206	-	206
Acquisition of NCI without a change in control	-	-	-	-	(22)	(22)	(10)	(32)
Acquisition (divestment) of subsidiary with NCI	-	-	-	-	-	-	(1)	(1)
Repurchase of shares	-	-	(309)	-	-	(309)	-	(309)
Transfer	-	-	-	(30)	30	-	-	-
Other	-	-	-	(3)	3	-	3	3
Total comprehensive income	-	-	-	(296)	483	187	(2)	185
Balance at 31 December 2020	338	489	(976)	(243)	7,791	7,399	88	7,487